新制度经济学视角下的我国药品集中采购政策分析

Analysis of China’s Centralized Drug Purchase Policy from the Perspective of New Institutional Economics

药品集中采购是药品分散采购市场出现问题后的制度选择。自其试点运行以来,药品集中招标采购在降药价、规范药品流通秩序、净化药品市场环境等方面获得了较大成效,逐步发展为我国药品流通的主导模式。文章从新制度经济学的角度去分析药品集中招标采购制度,认识其制度内涵,对认清药品集中招标采购制度完善的方向具有一定的指导意义。

Centralized procurement of drugs is the institutional choice after having problems in the drug decentralized procurement market.Since its pilot operation,the centralized bidding and procurement of drugs has achieved certain results in reducing the price of drugs,regulating the order of drug circulation,purifying the circulation market,and gradually becoming the main mode of drug circulation in China.It analyzes the centralized bidding and purchasing system of medicines from the perspective of new institutional economics,and understands the connotation of its system.It has certain guiding significance for recognizing the direction of perfecting the centralized bidding procurement system.